icon

Periodic/Annual financial statements

فارسی
Company:
گروه دارويي سبحان
Listed capital:
2,735,000
Symbol:
دسبحا
Unauthorized capital:
0
ISIC Code:
432321
Periodic/Annual financial statements  6 monthly End to 1397/06/31 (Unaudited)
Year end to date:
1397/12/29
Publisher status:
پذيرفته شده در بورس تهران
information The displayed data is matche to signed data.

All amounts are in Million rials

Export To Excel

DescriptionEnd of real to
1397/06/31
End of past financial year
1396/12/29
Percent of
changes
DescriptionEnd of real to
1397/06/31
End of past financial year
1396/12/29
Percent of
changes
Current assets Liabilities
Current assets Current liabilities
Cash 4,255 868 390 Commercial payments 0 0 --
Current investments 0 0 -- Non-commercial payments 9,214 3,612 155
Trade receivables 254,695 1,493,468 (83) Current tax liabilities 0 0 --
Non-trade receivables 110,862 98,958 12 Dividend payables 1,197,688 235,208 409
Current prepayments 787 537 47 Current financial liabilities at amortised cost 0 0 --
Non-current assets or disposal groups classified as held for sale or as held for distribution to owners 0 0 -- Provisions 0 0 --
Total Current assets 370,599 1,593,831 (77) Deferred income classified as current 0 0 --
Non-current assets Liabilities included in disposal groups classified as held for sale 0 0 --
Non-current receivables 1,045,928 32,652 3,103 Total Current liabilities 1,206,902 238,820 405
Non-current investments 2,201,379 2,235,422 (2) Non-current liabilities
Investment property 0 0 -- Non-current payables 2,332 2,583 (10)
Intangible assets other than goodwill 377 6 6,183 Deferred income classified as non-current 0 0 --
Property, plant and equipment 2,067 1,478 40 Non-Current financial liabilities at amortised cost 0 0 --
Other assets 0 0 -- Provisions for employee benefits 1,653 1,577 5
Total Non-current assets 3,249,751 2,269,558 43 Total Non-current liabilities 3,985 4,160 (4)
Total Liabilities 1,210,887 242,980 398
Equity
Issued capital 1,670,000 1,375,000 21
In-process capital increase 0 295,000 --
Share premium 0 0 --
Treasury shares 0 0 --
Statutory reserve 137,500 137,500 0
Other reserves 0 0 --
Revaluation surplus of non-current assets held for sale 0 0 --
Revaluation surplus 0 0 --
Exchange differences on translation‌ 0 0 --
Exchange reserve for governmental corporations' assets and liabilities 0 0 --
Retained earnings 601,963 1,812,909 (67)
Total Equity 2,409,463 3,620,409 (33)
Total Assets 3,620,350 3,863,389 (6) Total Equity and liabilities 3,620,350 3,863,389 (6)